AU533715B2 - Parenteral solution - Google Patents

Parenteral solution

Info

Publication number
AU533715B2
AU533715B2 AU64004/80A AU6400480A AU533715B2 AU 533715 B2 AU533715 B2 AU 533715B2 AU 64004/80 A AU64004/80 A AU 64004/80A AU 6400480 A AU6400480 A AU 6400480A AU 533715 B2 AU533715 B2 AU 533715B2
Authority
AU
Australia
Prior art keywords
parenteral solution
parenteral
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU64004/80A
Other languages
English (en)
Other versions
AU6400480A (en
Inventor
Maria Gazdag
Gabor Szepesi
Geza Takacsi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of AU6400480A publication Critical patent/AU6400480A/en
Application granted granted Critical
Publication of AU533715B2 publication Critical patent/AU533715B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU64004/80A 1979-11-02 1980-10-31 Parenteral solution Ceased AU533715B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU79RI733A HU181940B (en) 1979-11-02 1979-11-02 Process for producing solutions of vincane derivatives for parentheral application
HURI-733 1979-11-02

Publications (2)

Publication Number Publication Date
AU6400480A AU6400480A (en) 1981-05-07
AU533715B2 true AU533715B2 (en) 1983-12-08

Family

ID=11001115

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64004/80A Ceased AU533715B2 (en) 1979-11-02 1980-10-31 Parenteral solution

Country Status (24)

Country Link
US (1) US4344950A (OSRAM)
JP (1) JPS56123911A (OSRAM)
AR (1) AR223735A1 (OSRAM)
AT (1) AT377914B (OSRAM)
AU (1) AU533715B2 (OSRAM)
BE (1) BE885987A (OSRAM)
CA (1) CA1159367A (OSRAM)
CH (1) CH645019A5 (OSRAM)
CS (1) CS226417B2 (OSRAM)
DD (1) DD153760A5 (OSRAM)
DE (1) DE3041368A1 (OSRAM)
DK (1) DK464680A (OSRAM)
FI (1) FI803401L (OSRAM)
FR (1) FR2468373A1 (OSRAM)
GB (1) GB2062464B (OSRAM)
HU (1) HU181940B (OSRAM)
IL (1) IL61310A (OSRAM)
IT (1) IT1209367B (OSRAM)
NL (1) NL8005980A (OSRAM)
NO (1) NO803254L (OSRAM)
PH (1) PH17037A (OSRAM)
SE (1) SE8007569L (OSRAM)
YU (1) YU278880A (OSRAM)
ZA (1) ZA806468B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺
CN112649522B (zh) * 2020-11-30 2022-02-22 海南葫芦娃药业集团股份有限公司 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
US3159542A (en) * 1962-12-31 1964-12-01 American Cyanamid Co Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891B1 (OSRAM) * 1972-07-13 1975-08-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Also Published As

Publication number Publication date
CS226417B2 (en) 1984-03-19
IL61310A0 (en) 1980-12-31
GB2062464A (en) 1981-05-28
FR2468373A1 (fr) 1981-05-08
DK464680A (da) 1981-05-03
ZA806468B (en) 1981-10-28
BE885987A (fr) 1981-02-16
FI803401A7 (fi) 1981-05-03
IT8025683A0 (it) 1980-10-31
CH645019A5 (de) 1984-09-14
SE8007569L (sv) 1981-05-03
HU181940B (en) 1983-11-28
JPS56123911A (en) 1981-09-29
IL61310A (en) 1984-08-31
DD153760A5 (de) 1982-02-03
FI803401L (fi) 1981-05-03
PH17037A (en) 1984-05-17
US4344950A (en) 1982-08-17
YU278880A (en) 1984-04-30
AR223735A1 (es) 1981-09-15
FR2468373B1 (OSRAM) 1984-12-28
AT377914B (de) 1985-05-28
GB2062464B (en) 1983-12-07
CA1159367A (en) 1983-12-27
NL8005980A (nl) 1981-06-01
NO803254L (no) 1981-05-04
ATA527980A (de) 1984-10-15
DE3041368A1 (de) 1981-05-14
AU6400480A (en) 1981-05-07
IT1209367B (it) 1989-07-16

Similar Documents

Publication Publication Date Title
AU532879B2 (en) 1-aryl-2-acylamido-3-fluoro-1-propanols
AU532626B2 (en) Monacolink
AU2489984A (en) Arylsulphonyls
AU532090B2 (en) Emmitter
AU537066B2 (en) Coin-validating arrangement
AU532783B2 (en) 4-aroyl-imazol-2-ones
AU533526B2 (en) Polyether-polyamines
AU529508B2 (en) 6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU525431B2 (en) Emulsans
AU532884B2 (en) Vinyl-cephalosporins
AU528665B2 (en) Breathalyser
AU527992B2 (en) 9-aminoalkylfluorenes
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU533807B2 (en) Pyridothienotriazines
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU532359B2 (en) 2-amino-3-benzoyl-phenylacetamides
AU531811B2 (en) Thiazolylidene-oxo-propionitriles
AU532700B2 (en) Diphenylalkanoether
AU528075B2 (en) Z-aza-ergolines
AU533715B2 (en) Parenteral solution
AU535376B2 (en) N-oximinoalkyl-anilides
AU534662B2 (en) Azolyl-alkenols
AU531825B2 (en) 4-beta-substituted-2-azetidinones
AU533016B2 (en) 4-phenylthioalkanesulfonanilides
AU534329B2 (en) Guanioinothiazoles